Latest news with #ModernaJapan

Nikkei Asia

Moderna cancels Japan mRNA plant plans amid weak demand

Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business environment. YURIKA YONEDA TOKYO -- U.S. drugmaker Moderna has scrapped plans to build a messenger RNA (mRNA) vaccine plant in Japan, citing sluggish vaccine demand and poor business performance. "After careful consideration in light of the current business environment, we have decided not to proceed with this plan at this time," Moderna's Japanese subsidiary stated in a news release on Friday.